Ekso Bionics Holdings Inc (EKSO)

[Rhetorical]

Now is such a critical time. The stock is nearing a 52 week low and yet two new products were just launched. Meanwhile, it is very close to a net positive EPS before Q3 - excited to see the numbers next 10-Q.

I think the UE suits have great promise, but I'd like to know more about the NR and conversion/prices. Still, it's new revenue streams and I would guess most of the cost of production is already paid for. Going ahead, if production costs slow down temporarily, I think this could easily put us over the top into positive EPS, which could easily be a windfall and majorly boost share price.

I think one the most critical numbers to ground things looking forward will be how many existing customers upgrade from GT to NR; something perhaps even more telling than new purchases. I wish I knew what upgrading costs, if anyone else knows?... What percent of production has moved abroad would also be a great figure, but I don't expect it'll be quantified.

I'm skeptical of the board post on here suggesting a doubling of sales staff. I'd like to trust it, but I don't with out more evidence.

Anyhow, I'm long EKSO. Looking forward to hearing other people's thoughts.